City State Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
City State Bank's BMY Position: Q2 2026 in Review
City State Bank increased its Bristol-Myers Squibb (BMY) stake by 4.3% in Q2 2026, buying an estimated $19.8K and bringing the position to 8,431 shares worth $486K. The position accounts for 0.11% of the portfolio, ranked #135.
City State Bank first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.04M in Q2 2022. 888 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- City State Bank held 8,431 shares of Bristol-Myers Squibb worth $486K as of Q2 2026.
- City State Bank bought 345 Bristol-Myers Squibb shares in Q2 2026, an estimated $19.8K.
- Bristol-Myers Squibb made up 0.11% of City State Bank's portfolio in Q2 2026, its #135 holding.
- City State Bank first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- City State Bank's Bristol-Myers Squibb position peaked at $1.04M in Q2 2022.
- 888 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.